Gynov is a BtoB pharmaceutical company based in Bordeaux, France. Since 2016, their commitment has been towards women's health, providing support throughout their lives. Their products, backed by robust scientific data and complying with the pharmaceutical quality process, are distributed in over 20 countries. Their last investment was a Corporate Round investment on 25 November 2021, led by eureKARE. Gynov's slogan, "Engagé pour la santé de toutes les femmes", reflects their dedication to the health of all women. With a focus on the health care and pharmaceutical industries, Gynov is positioned to make a significant impact in the global market.
No recent news or press coverage available for Gynov.